{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:04:35Z","timestamp":1793120675741,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T00:00:00Z","timestamp":1253232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T00:00:00Z","timestamp":1253232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/nri2629","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T14:26:58Z","timestamp":1253284018000},"page":"741-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":282,"title":["Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology"],"prefix":"10.1038","volume":"9","author":[{"given":"Bali","family":"Pulendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,18]]},"reference":[{"key":"BFnri2629_CR1","first-page":"95","volume-title":"Microbe Hunters \u2014 Then and Now","author":"TP Monath","year":"1996","unstructured":"Monath, T. P. in Microbe Hunters \u2014 Then and Now (eds Oldstone, M. & Koprowski, H.) 95\u2013111 (Medi-Ed, Bloomington, Illinois, 1996)."},{"key":"BFnri2629_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1586\/14760584.4.4.553","volume":"4","author":"TP Monath","year":"2005","unstructured":"Monath, T. P. Yellow fever vaccine. Expert Rev. Vaccines 4, 553\u2013574 (2005).","journal-title":"Expert Rev. Vaccines"},{"key":"BFnri2629_CR3","doi-asserted-by":"crossref","unstructured":"Barrett, A. D. T. & Teuwen, D. Yellow fever vaccine \u2014 how does it work and why do rare cases of serious adverse events take place? Curr. Opin. Immunol. 21, 1\u20136 (2009).","DOI":"10.1016\/j.coi.2009.05.018"},{"key":"BFnri2629_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1084\/jem.65.6.767","volume":"65","author":"M Theiler","year":"1937","unstructured":"Theiler, M. & Smith, H. H. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J. Exp. Med. 65, 767\u2013786 (1937).","journal-title":"J. Exp. Med."},{"key":"BFnri2629_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1084\/jem.65.6.787","volume":"65","author":"M Theiler","year":"1937","unstructured":"Theiler, M. & Smith, H. H. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787\u2013800 (1937).","journal-title":"J. Exp. Med."},{"key":"BFnri2629_CR6","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","volume":"84","author":"CS Hahn","year":"1987","unstructured":"Hahn, C. S., Dalrymple, J. M., Strauss, J. M. & Rice, C. M. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl Acad. Sci. USA 84, 2019\u20132023 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2629_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/viro.1997.8496","volume":"230","author":"KD Ryman","year":"1997","unstructured":"Ryman, K. D., Xie, H., Ledger, T. N., Campbell, G. A. & Barrett, A. D. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology 230, 376\u2013380 (1997).","journal-title":"Virology"},{"key":"BFnri2629_CR8","doi-asserted-by":"publisher","first-page":"9998","DOI":"10.1128\/JVI.78.18.9998-10008.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo, F. et al. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia\/viscerotropism for monkeys. J. Virol. 78, 9998\u201310008 (2004).","journal-title":"J. Virol."},{"key":"BFnri2629_CR9","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1128\/JVI.76.4.1932-1943.2002","volume":"76","author":"TP Monath","year":"2002","unstructured":"Monath, T. P. et al. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76, 1932\u20131943 (2002).","journal-title":"J. Virol."},{"key":"BFnri2629_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1099\/0022-1317-77-6-1277","volume":"77","author":"JJ Schlesinger","year":"1996","unstructured":"Schlesinger, J. J. et al. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J. Gen. Virol. 77, 1277\u20131285 (1996).","journal-title":"J. Gen. Virol."},{"key":"BFnri2629_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","volume":"56","author":"B Reinhardt","year":"1998","unstructured":"Reinhardt, B., Jaspert, R., Niedrig, M., Kostner, C. & L'Age-Stehr, J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J. Med. Virol. 56, 159\u2013167 (1998).","journal-title":"J. Med. Virol."},{"key":"BFnri2629_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.2001.1255","volume":"293","author":"MD Co","year":"2002","unstructured":"Co, M. D., Terajima, M., Cruz, J., Ennis, F. A. & Rothman, A. L. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293, 151\u2013163 (2002).","journal-title":"Virology"},{"key":"BFnri2629_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","volume":"28","author":"JD Miller","year":"2008","unstructured":"Miller, J. D. et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28, 710\u2013722 (2008).","journal-title":"Immunity"},{"key":"BFnri2629_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01320562","volume":"48","author":"TS David-West","year":"1975","unstructured":"David-West, T. S. Concurrent and consecutive infection and immunisations with yellow fever and UGMP-359 viruses. Arch. Virol. 48, 21\u201328 (1975).","journal-title":"Arch. Virol."},{"key":"BFnri2629_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","volume":"1","author":"AB Sabin","year":"1952","unstructured":"Sabin, A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30\u201350 (1952).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFnri2629_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","volume":"227","author":"O Takeuchi","year":"2009","unstructured":"Takeuchi, O. & Akira, S. Innate immunity to virus infection. Immunol. Rev. 227, 75\u201386 (2009).","journal-title":"Immunol. Rev."},{"key":"BFnri2629_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature06175","volume":"449","author":"RM Steinman","year":"2007","unstructured":"Steinman, R. M. & Banchereau, J. Taking dendritic cells into medicine. Nature 449, 419\u2013426 (2007).","journal-title":"Nature"},{"key":"BFnri2629_CR18","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.4049\/jimmunol.174.5.2457","volume":"174","author":"B Pulendran","year":"2005","unstructured":"Pulendran, B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 174, 2457\u20132465 (2005).","journal-title":"J. Immunol."},{"key":"BFnri2629_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20051720","volume":"203","author":"T Querec","year":"2006","unstructured":"Querec, T. et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203, 413\u2013424 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnri2629_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","volume":"17","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov, D. D., Ali, S. M. & Sabatini, D. M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596\u2013603 (2005).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnri2629_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ni.1645","volume":"9","author":"W Cao","year":"2008","unstructured":"Cao, W. et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S76K pathway. Nature Immunol. 9, 1157\u20131164 (2008).","journal-title":"Nature Immunol."},{"key":"BFnri2629_CR22","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20051352","volume":"202","author":"G Barba-Spaeth","year":"2005","unstructured":"Barba-Spaeth, G., Longman, R. S., Albert, M. L. & Rice, C. M. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J. Exp. Med. 202, 1179\u20131184 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri2629_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1099\/vir.0.82272-0","volume":"88","author":"DR Palmer","year":"2007","unstructured":"Palmer, D. R. et al. Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells. J. Gen. Virol. 88, 148\u2013156 (2007).","journal-title":"J. Gen. Virol."},{"key":"BFnri2629_CR24","volume-title":"Conjectures and Refutations","author":"K Popper","year":"1963","unstructured":"Popper, K. Conjectures and Refutations (Routledge and Keagan Paul, London, 1963)."},{"key":"BFnri2629_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503\u2013511 (2000).","journal-title":"Nature"},{"key":"BFnri2629_CR26","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nm1491","volume":"12","author":"A Potti","year":"2006","unstructured":"Potti, A. et al. Genomic signatures to guide the use of chemotherapeutics. Nature Med. 12, 1294\u20131300 (2006).","journal-title":"Nature Med."},{"key":"BFnri2629_CR27","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869\u201310874 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri2629_CR28","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood-2006-02-002477","volume":"109","author":"O Ramilo","year":"2007","unstructured":"Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066\u20132077 (2007).","journal-title":"Blood"},{"key":"BFnri2629_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","volume":"29","author":"D Chaussabel","year":"2008","unstructured":"Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150\u2013164 (2008).","journal-title":"Immunity"},{"key":"BFnri2629_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"TD Querec","year":"2009","unstructured":"Querec, T. D. et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature Immunol. 10, 116\u2013125 (2009).","journal-title":"Nature Immunol."},{"key":"BFnri2629_CR31","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher, D. et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119\u20133131 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri2629_CR32","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.4049\/jimmunol.177.5.3185","volume":"177","author":"JP Chen","year":"2006","unstructured":"Chen, J. P. et al. Dengue virus induces expression of CXC chemokine ligand 10\/IFN-\u03b3-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J. Immunol. 177, 3185\u20133192 (2006).","journal-title":"J. Immunol."},{"key":"BFnri2629_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/jmv.20205","volume":"74","author":"K Shirato","year":"2004","unstructured":"Shirato, K., Kimura, T., Mizutani, T., Kariwa, H. & Takashima, I. Different chemokine expression in lethal and non-lethal murine West Nile virus infection. J. Med. Virol. 74, 507\u2013513 (2004).","journal-title":"J. Med. Virol."},{"key":"BFnri2629_CR34","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.4049\/jimmunol.175.8.5260","volume":"175","author":"S Rothenfusser","year":"2005","unstructured":"Rothenfusser, S. et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175, 5260\u20135268 (2005).","journal-title":"J. Immunol."},{"key":"BFnri2629_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/138920207780368187","volume":"8","author":"FQ Zhao","year":"2007","unstructured":"Zhao, F. Q. & Keating, A. F. Functional properties and genomics of glucose transporters. Curr. Genomics 8, 113\u2013128 (2007).","journal-title":"Curr. Genomics"},{"key":"BFnri2629_CR36","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature03205","volume":"433","author":"JD Richter","year":"2005","unstructured":"Richter, J. D. & Sonenberg, N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 433, 477\u2013480 (2005).","journal-title":"Nature"},{"key":"BFnri2629_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0076-6879(07)31005-7","volume":"431","author":"N Kedersha","year":"2007","unstructured":"Kedersha, N. & Anderson, P. Mammalian stress granules and processing bodies. Methods Enzymol. 431, 61\u201381 (2007).","journal-title":"Methods Enzymol."},{"key":"BFnri2629_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron, D. & Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Rev. Mol. Cell Biol. 8, 519\u2013529 (2007).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnri2629_CR39","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","volume":"13","author":"RJ Kaufman","year":"1999","unstructured":"Kaufman, R. J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13, 1211\u20131233 (1999).","journal-title":"Genes Dev."},{"key":"BFnri2629_CR40","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/sj.emboj.7601073","volume":"25","author":"JJ Berlanga","year":"2006","unstructured":"Berlanga, J. J. et al. Antiviral effect of the mammalian translation initiation factor 2\u03b1 kinase GCN2 against RNA viruses. EMBO J. 25, 1730\u20131740 (2006).","journal-title":"EMBO J."},{"key":"BFnri2629_CR41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.smim.2006.06.001","volume":"18","author":"RT Woodland","year":"2006","unstructured":"Woodland, R. T., Schmidt, M. R. & Thompson, C. B. BLyS and B cell homeostasis. Semin. Immunol. 18, 318\u2013326 (2006).","journal-title":"Semin. Immunol."},{"key":"BFnri2629_CR42","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","volume":"23","author":"AY Khromava","year":"2005","unstructured":"Khromava, A. Y. et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23, 3256\u20133263 (2005).","journal-title":"Vaccine"},{"key":"BFnri2629_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/viro.2001.1168","volume":"290","author":"R Galler","year":"2001","unstructured":"Galler, R., Pugachev, V., Santos, L. S., Ocran, S. W. & Monath, T. P. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 290, 309\u2013319 (2001).","journal-title":"Virology"},{"key":"BFnri2629_CR44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1086\/587844","volume":"197","author":"HG Bae","year":"2008","unstructured":"Bae, H. G. et al. Immune response during adverse events after 17D-derived yellow fever vaccination in Europe. J. Infect. Dis. 197, 1577\u20131584 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnri2629_CR45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1086\/590187","volume":"198","author":"B Pulendran","year":"2008","unstructured":"Pulendran, B. et al. Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J. Infect. Dis. 198, 500\u2013507 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnri2629_CR46","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","volume":"25","author":"JL Belsher","year":"2007","unstructured":"Belsher, J. L. et al. Fatal multi-organ failure due to yellow fever vaccine associated viscerotropic disease. Vaccine 25, 8480\u20138485 (2007).","journal-title":"Vaccine"},{"key":"BFnri2629_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","volume":"45","author":"AP Santos","year":"2008","unstructured":"Santos, A. P., Matos, D. C., Bertho, A. L., Mendonca, S. C. & Marcovistz, R. Detection of TH1\/TH2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. Cytokine 45, 152\u2013155 (2008).","journal-title":"Cytokine"},{"key":"BFnri2629_CR48","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","volume":"26","author":"MA Martins","year":"2008","unstructured":"Martins, M. A. et al. Innate immunity phenotypic features point towards simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination. Vaccine 26, 1173\u20131184 (2008).","journal-title":"Vaccine"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri2629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri2629","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri2629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T07:50:24Z","timestamp":1744357824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri2629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,18]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFnri2629"],"URL":"https:\/\/doi.org\/10.1038\/nri2629","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,18]]},"assertion":[{"value":"18 September 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Bali Pulendran Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nature Reviews Immunology 2009 doi:10.1038\/nri2629 Part of the work described in this review was funded by a research grant from Sanofi Pasteur, who manufacture the yellow fever vaccine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}